Skip to main content
. 2015 Apr 15;26(8):1416–1427. doi: 10.1091/mbc.E14-11-1576

FIGURE 5:

FIGURE 5:

MiR-1188 mediates invasion and apoptosis by modulating Bcl-2 and Sp1 levels. (A, B) qRT-PCR analysis showed the relative levels of Bcl-2 and Sp1 in Hepa1-6 cells transfected with NC or siRNA, respectively. (C, D) Immunoblot analysis of Bcl-2 and Sp1 in Hepa1-6 cells transfected with siRNA. (E) Representative growth curves corresponding to Hepa1-6 cells transfected with NC or si-Sp1-588. (F) Migration and invasion of Hepa1-6 cells transfected with NC or si-Sp1-588. (G) Annexin V–FITC/PI staining of cells cotransfected with NC or miR-1188 inhibitor and/or si-Bcl-2 for 20 h. (H, I) Immunoblot analysis showed that the levels of Bcl-2 and Sp1 were changed in Hepa1-6 cells transfected with miR-1188 mimics, miR-1188 inhibitor, si-Bcl-2, or si-Sp1. More significantly, miR-1188 inhibitor rescued the level of Bcl-2 or Sp1 in cells cotransfected with inhibitor and siRNAs compared with cells transfected with siRNA alone. Error bars represent the SE obtained from three independent experiments; *p < 0.05, **p < 0.01, ***p < 0.001.